Cancer drug reverses Alzheimer's in mice
By Joseph Brownstein,
MyHealthNewsDailyA cancer drug has succeeded in reversing Alzheimer's disease in its early stages in mice, according to a new study.
The drug, bexarotene, is designed to reduce levels of amyloid beta, the protein whose presence in the brain has been most closely tied to the development of Alzheimer's.
Where are we with biomarker diagnosis and other tests for Alzheimer's Disease?
Watch Steven T. DeKosky, MD discuss testing issues in the following short video clips.
Copyright © 2013 by the Rector and Visitors of the University of Virginia
Office of Continuing Medical Education
P.O. Box 800711 Charlottesville, VA 22908
phone 434–924–5310 | fax 434–982–1415
Programming and Development by
